New
Image

15.08.2025
Novo Nordisk to withdraw Levemir insulin – here's what you need to know
The drug manufacturer Novo Nordisk has announced it will withdraw Levemir insulin in all forms by the end...
customer support
customer support
We take a look at some of the exciting diabetes research developments announced in July, including how teplizumab targets type 1 diabetes and understanding the risk of eating disorders for people taking part in type 2 diabetes remission programmes.
Read more